Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, has commenced manufacturing Panadol 500mg tablets at its Jamshoro facility, marking a shift towards in-house production of the popular pain relief medicine. The company, which is primarily engaged in the manufacturing, marketing, and sale of consumer healthcare and over-the-counter (OTC) health prod